Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debanjali Mitra

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Medical Care|January 17, 2007
The effect of screening and brief intervention for risky drinking on health care utilization in managed care organizationsJeremy W Bray, Gary A Zarkin, Keith L Davis, et al.
Cancer Medicine|January 10, 2014
Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record reviewDebanjali Mitra, James A Kaye, Lance T Piecoro, et al.
Clinical Therapeutics|December 1, 2022
Real-world Treatment Patterns and Clinical Outcomes Associated With Palbociclib Combination Therapy: A Multinational, Pooled Analysis From the Ibrance Real World Insights StudyKatie Mycock, Kent A Hanson, Gavin Taylor-Stokes, et al.
Archives of General Psychiatry|October 8, 2008
Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patientsGary A Zarkin, Jeremy W Bray, Arnie Aldridge, et al.
Clinical Therapeutics|July 14, 2021
Health-Related Quality of Life Among Patients With HR+/HER2- Early Breast CancerCarmen Criscitiello, Dean Spurden, James Piercy, et al.
Journal of Studies on Alcohol and Drugs|February 9, 2007
Measuring economic outcomes of alcohol treatment using the Economic Form 90Jeremy W Bray, Gary A Zarkin, William R Miller, et al.
Breast Cancer Research and Treatment|January 11, 2021
A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile applicationDavid Richardson, Lin Zhan, Reshma Mahtani, et al.
Breast (Edinburgh, Scotland)|August 22, 2021
Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by raceJifang Zhou, Jenilee Cueto, Naomi Y Ko, et al.
Cancer Causes & Control : CCC|February 28, 2022
Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancerGregory S Calip, Nadia A Nabulsi, Colin Hubbard, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US Syapse Learning Health NetworkJeanna Wallenta Law, Debanjali Mitra, Henry G Kaplan, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Medical Care|January 17, 2007
The effect of screening and brief intervention for risky drinking on health care utilization in managed care organizationsJeremy W Bray, Gary A Zarkin, Keith L Davis, et al.
Cancer Medicine|January 10, 2014
Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record reviewDebanjali Mitra, James A Kaye, Lance T Piecoro, et al.
Clinical Therapeutics|December 1, 2022
Real-world Treatment Patterns and Clinical Outcomes Associated With Palbociclib Combination Therapy: A Multinational, Pooled Analysis From the Ibrance Real World Insights StudyKatie Mycock, Kent A Hanson, Gavin Taylor-Stokes, et al.
Archives of General Psychiatry|October 8, 2008
Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patientsGary A Zarkin, Jeremy W Bray, Arnie Aldridge, et al.
Clinical Therapeutics|July 14, 2021
Health-Related Quality of Life Among Patients With HR+/HER2- Early Breast CancerCarmen Criscitiello, Dean Spurden, James Piercy, et al.
Journal of Studies on Alcohol and Drugs|February 9, 2007
Measuring economic outcomes of alcohol treatment using the Economic Form 90Jeremy W Bray, Gary A Zarkin, William R Miller, et al.
Breast Cancer Research and Treatment|January 11, 2021
A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile applicationDavid Richardson, Lin Zhan, Reshma Mahtani, et al.
Breast (Edinburgh, Scotland)|August 22, 2021
Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by raceJifang Zhou, Jenilee Cueto, Naomi Y Ko, et al.
Cancer Causes & Control : CCC|February 28, 2022
Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancerGregory S Calip, Nadia A Nabulsi, Colin Hubbard, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US Syapse Learning Health NetworkJeanna Wallenta Law, Debanjali Mitra, Henry G Kaplan, et al.
Pageof 5